Finding 1158153 (2024-001)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2025-09-30
Audit: 370077
Organization: The Scintillon Institute (CA)
Auditor: Leaf & Cole LLP

Finding Text

No text available

Categories

No categories assigned yet.

Other Findings in this Audit

  • 1158152 2024-001
    Material Weakness Repeat
  • 1158154 2024-001
    Material Weakness Repeat
  • 1158155 2024-001
    Material Weakness Repeat
  • 1158156 2024-001
    Material Weakness Repeat
  • 1158157 2024-001
    Material Weakness Repeat
  • 1158158 2024-001
    Material Weakness Repeat
  • 1158159 2024-001
    Material Weakness Repeat
  • 1158160 2024-001
    Material Weakness Repeat
  • 1158161 2024-001
    Material Weakness Repeat
  • 1158162 2024-001
    Material Weakness Repeat
  • 1158163 2024-001
    Material Weakness Repeat
  • 1158164 2024-001
    Material Weakness Repeat
  • 1158165 2024-001
    Material Weakness Repeat
  • 1158166 2024-001
    Material Weakness Repeat
  • 1158167 2024-001
    Material Weakness Repeat
  • 1158168 2024-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $982,724
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $437,876
93.837 Cardiovascular Diseases Research $218,316
93.113 Environmental Health $212,011
93.173 Research Related to Deafness and Communication Disorders $211,344
93.866 Aging Research $72,893
93.396 Cancer Biology Research $70,434
12.420 Military Medical Research and Development $68,723
93.395 Cancer Treatment Research $57,605
93.859 Biomedical Research and Research Training $42,515
93.310 Trans-Nih Research Support $1,064
93.855 Allergy and Infectious Diseases Research $-8,042